Thetration is depending upon physicians to fulfill their part of a mutual responsibility—the careful and judicious administration of medication.
This was the message brought to physicians by the FDA's new medical director when he addressed a session of the American Medical Association's 113th Annual Convention in San Francisco in June.
Joseph F. Sadusk, Jr, MD, at his post since April 1, journeyed to the West Coast meeting to explain his concept of the relationship between the physician and the FDA. The relationship is a close one, he said, and growing closer.
"The Congress, in public interest, has charged the FDA with the responsibility of seeing that the profession is provided with safe and effective drugs for their patients, and with adequate information for the safe and effective use of these drugs," said Sadusk. "Consequently, the physician and the FDA have a mutual interest—and this carries with it a mutual reponsibility—in